The binding of KD033 to PD-L1+ tumor cells seemed to focus the IL-15 responses as KD033 could act as the costimulatory signal and checkpoint blocker for CD8+ T cells when KD033is bound to PD-L1+ tumor cells. Here, CD8A is linked to neoplasm.